Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study

被引:8
|
作者
Perinel, Julie [1 ]
Nappo, Gennaro [2 ]
Zerbi, Alessandro [2 ,3 ]
Heidsma, Charlotte M. [4 ]
van Dijkum, Elisabeth J. M. Nieveen [4 ]
Han, Ho Seong [5 ]
Yoon, Yoo-Seok [5 ]
Satoi, Sohei [6 ,7 ]
Demir, Ihsan Ekin [8 ]
Friess, Helmut [8 ]
Vashist, Yogesh [9 ]
Izbicki, Jakob [10 ]
Muller, Alexandra Charlotte [11 ]
Gloor, Beat [11 ]
Sandini, Marta [12 ,13 ]
Gianotti, Luca [12 ,13 ]
Subtil, Fabien [14 ]
Adham, Mustapha [1 ]
机构
[1] UCBL1, Hosp Civils Lyon, Lyon Sud Fac Med, Dept Digest Surg,E Herriot Hosp, Lyon, France
[2] Humanitas Clin & Res Ctr IRCCS Rozzano, Pancreat Surg Unit, Milan, Italy
[3] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[4] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Surg, Amsterdam, Netherlands
[5] Seoul Natl Univ, Coll Med, Dept Surg, Bundang Hosp, Seoul, South Korea
[6] Kansai Med Univ, Dept Surg, Osaka, Japan
[7] Univ Colorado, Div Surg Oncol, Anschutz Med Campus, Aurora, CO USA
[8] Tech Univ Munich, Dept Surg, Fac Med, Munich, Germany
[9] Medias Klinikum, Ctr Surg Oncol, Burghausen, Germany
[10] Clin Univ Med Ctr Hamburg Eppendorf, Gen Visceral & Thorac Surg Dept, Hamburg, Germany
[11] Univ Hosp Bern, Inselspital, Bern, Switzerland
[12] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy
[13] San Gerardo Hosp, Dept Surg, Monza, Italy
[14] Hosp Civils Lyon, Serv Biostat, UCBLUMR CNRS 5558, LBBE, Lyon, France
关键词
SURGICAL-MANAGEMENT; RESECTION; SURGERY; CM; STRATEGY; SURVIVAL; CLASSIFICATION; COMPLICATIONS; SURVEILLANCE; INVOLVEMENT;
D O I
10.1016/j.surg.2022.04.013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Although the correlation between tumor size and aggressiveness is clearly established in sporadic nonfunctional pancreatic neuroendocrine tumors, the management of tumors <= 2 cm remains debated. In recent guidelines, the cut-off size to operate ranged from 1 to 2 cm. The aim of this retrospective study was to report the rate of lymph nodes metastases in resected sporadic nonfunctional pancreatic neuroendocrine tumors, according to tumor size and, second, to identify risk factors of lymph node metastases and disease-free survival. Methods: Resected sporadic nonfunctional pancreatic neuroendocrine tumors from 9 international expert centers were included (1999-2017). Functional pancreatic neuroendocrine tumors, genetic syndromes, and R2 resection were excluded. Aggressiveness was defined as microvascular invasion, perineural invasion, lymph node metastases, G3 grading, distant metastases, and/or recurrence. Results: Overall, 495 resected sporadic nonfunctional pancreatic neuroendocrine tumors were included. For tumors up to 5 cm, the risk of lymph node metastases was increased by 1.73 for every 1 cm increase in size (odds ratio = 1.73; 95% confidence interval = 1.46-2.03). Tumor size >2 cm (P < .001), perineural invasion (P = .002), microvascular invasion (P < .001), and distant metastases (P =.008) were independently associated with lymph node metastases. Tumor size >2 cm (P = .003), R1 status (P = .004), lymph node metastases (P < .001), and World Health Organization grade 3 (P = .002) were independently associated with disease-free survival. Aggressiveness rate was 13.1% in tumors <= 1 cm and 29% in tumors between 1.1 and 2 cm. Conclusion: In resected sporadic nonfunctional pancreatic neuroendocrine tumors, the risk of lymph node metastases is correlated to tumor size. Considering that sporadic nonfunctional pancreatic neuroendocrine tumors between 1.1 and 2 cm had a higher risk of lymph node metastases and
引用
收藏
页码:975 / 981
页数:7
相关论文
共 50 条
  • [31] Serotonin Expression in Pancreatic Neuroendocrine Tumors Correlates with a Trabecular Histologic Pattern and Fewer Lymph Node Metastases
    McCall, C. M.
    Shi, C.
    Klein, A. P.
    Kloppel, G.
    Konukiewicz, B.
    Edil, B. H.
    Ellison, T.
    Hruban, R. H.
    LABORATORY INVESTIGATION, 2011, 91 : 369A - 369A
  • [32] Predictors of Lymph Node Metastases and Impact on Survival in Resected Pancreatic Neuroendocrine Tumors, a Single Center Experience
    Wong, Joyce
    Fulp, William J.
    Strosberg, Jonathan R.
    Kvols, Larry
    Hodul, Pamela
    GASTROENTEROLOGY, 2013, 144 (05) : S1127 - S1127
  • [33] Correlation Between Genomic Imbalances, Cell Proliferation and Tumor Size in Sporadic Pancreatic Neuroendocrine Tumors
    Haugvik, S. P.
    Gorunova, L.
    Haugom, L.
    Eibak, Eng A. M.
    Gladhaug, I. P.
    Heim, S.
    Heim, S.
    Micci, F.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 227 - 227
  • [34] Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study
    Ben, Qiwen
    Zhong, Jie
    Fei, Jian
    Chen, Haitao
    Yv, Lifen
    Tan, Jihong
    Yuan, Yaozong
    SCIENTIFIC REPORTS, 2016, 6
  • [35] Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study
    Qiwen Ben
    Jie Zhong
    Jian Fei
    Haitao Chen
    Lifen Yv
    Jihong Tan
    Yaozong Yuan
    Scientific Reports, 6
  • [36] Optimal lymph node dissection area for pancreatic neuroendocrine neoplasms by tumor location, size, and grade
    Murase, Yoshiki
    Esaki, Minoru
    Mizui, Takahiro
    Takamoto, Takeshi
    Nara, Satoshi
    Ban, Daisuke
    Hiraoka, Nobuyoshi
    Shimada, Kazuaki
    SURGERY, 2025, 180
  • [37] Development and Validation of Nomogram in Predicting Individualized Postoperative Survival for Nonfunctional Pancreatic Neuroendocrine Tumors: A Multicenter Retrospective Study
    Han, X.
    Ma, H.
    Feng, J.
    Xu, X.
    Wang, D.
    Kuang, T.
    Zhang, Y.
    Li, G.
    Song, B.
    He, J.
    Jin, G.
    Lou, W.
    NEUROENDOCRINOLOGY, 2016, 103 : 22 - 22
  • [38] RISK FACTORS FOR THE OCCURRENCE OF SPORADIC PANCREATIC NEUROENDOCRINE TUMOURS: A MULTICENTER EUROPEAN STUDY (EPINET)
    Valente, R.
    Hayes, A.
    Haugvik, S. P.
    Hedenstrom, P.
    Siuka, D.
    Maisonneuve, P.
    Delle Fave, G.
    Lindkvist, B.
    Capurso, G.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E70 - E70
  • [39] Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience
    Wong, Joyce
    Fulp, William J.
    Strosberg, Jonathan R.
    Kvols, Larry K.
    Centeno, Barbara A.
    Hodul, Pamela J.
    AMERICAN JOURNAL OF SURGERY, 2014, 208 (05): : 775 - 780
  • [40] Serotonin Expression in Pancreatic Neuroendocrine Tumors Correlates with a Trabecular Histologic Pattern and Fewer Lymph Node Metastases.
    McCall, C. M.
    Shi, C.
    Klein, A. P.
    Kloppel, G.
    Konukiewicz, B.
    Edil, B. H.
    Ellison, T.
    Hruban, R. H.
    MODERN PATHOLOGY, 2011, 24 : 369A - 369A